7th Circuit Won’t Stay Mandate In Medicare Drug Rebate False Claims Case

( December 4, 2025, 11:19 AM EST) -- CHICAGO — Arguments from Eli Lilly & Co. that the U.S. Supreme Court is likely to decide whether the Seventh Circuit U.S. Court of Appeals erred in affirming a final judgment of $193 million for reporting falsely deflated drug prices to the government were unpersuasive, the Seventh Circuit said in denying Lilly’s motion to stay the court’s mandate....

Attached Documents

Related Sections